kisqali 200mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - ribociklib - film tableta - 200mg
scemblix 20mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - asciminib - film tableta - 20mg
scemblix 40mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - asciminib - film tableta - 40mg
eucreas 50mg + 850mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - vildagliptin, metformin - film tableta - 50mg + 850mg
eucreas 50mg + 1000mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - vildagliptin, metformin - film tableta - 50mg + 1000mg
atectura breezhaler 125mcg + 260mcg prašak za inhalaciju, tvrda kapsula
"novartis pharma services ag" dio stranog druŠtva podgorica - indakaterol, mometazon - prašak za inhalaciju, tvrda kapsula - 125mcg + 260mcg
atectura breezhaler 125mcg + 127.5mcg prašak za inhalaciju, tvrda kapsula
"novartis pharma services ag" dio stranog druŠtva podgorica - indakaterol, mometazon - prašak za inhalaciju, tvrda kapsula - 125mcg + 127.5mcg
enerzair breezhaler 114mcg + 46mcg + 136mcg prašak za inhalaciju, tvrda kapsula
"novartis pharma services ag" dio stranog druŠtva podgorica - indakaterol, glikopironijum bromid, mometazon - prašak za inhalaciju, tvrda kapsula - 114mcg + 46mcg + 136mcg
gilenya 0.5mg kapsula, tvrda
"novartis pharma services ag" dio stranog druŠtva podgorica - fingolimod - kapsula, tvrda - 0.5mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).